VYNE Therapeutics Inc (VYNE)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$0.3761

Buy

$0.38

arrow-down$-0.0295 (-7.28%)

Prices updated at 12 Dec 2025, 21:41 EST

Prices minimum 15 mins delay

Prices in USD

Menlo Therapeutics Inc is a biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$0.41 - $0.37
	$4.30 - $0.28
	-
	12.50m
	-
	-
	1,239,398
	0.39
	1,162,468.40
	2.32
	14.83m
	US92941V3087
	-0.79
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.